PEGUS Research HistoryPEGUS began life in 1985 as a group of academic researchers conducting analyses of the data from Poison Control Center incident reports. Discussions over drinks between a member of the academic team and a friend from the pharmaceutical industry led to thinking about methods for gathering safety information about prescription drugs that might be suitable for non-prescription sale. This led to thinking, planning, and ultimately designing a study to assist American Home Products (now Wyeth) in their efforts to switch Children's Advil.
PEGUS was formally incorporated in 1992 and began work on two prospective observational studies of more than 44,000 children who received either Children's Advil or Children's Tylenol. Children's Advil was approved for OTC sale in 1996. Since then, PEGUS has worked on several OTC switch programs and has worked to define procedures for the conduct of such research. Over the decade and a half since we began formal operations, we have also gained expertise in a wide variety of health-related and market research areas.